Page last updated: 2024-09-03

ginsenoside rh2 and docetaxel anhydrous

ginsenoside rh2 has been researched along with docetaxel anhydrous in 2 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010) (docetaxel anhydrous)
295120012,1103,2166,920

Protein Interaction Comparison

ProteinTaxonomyginsenoside rh2 (IC50)docetaxel anhydrous (IC50)
Kinesin-like protein KIF11Homo sapiens (human)0.0014
Nucleotide-binding oligomerization domain-containing protein 2Homo sapiens (human)5.0119

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adomat, H; Bally, MB; Eberding, A; Fazli, L; Guns, ET; Hurtado-Coll, A; Jia, W; Musende, AG; Wood, C1
Bally, MB; Eberding, A; Guns, ET; Jia, W; Musende, AG; Ramsay, E1

Other Studies

2 other study(ies) available for ginsenoside rh2 and docetaxel anhydrous

ArticleYear
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
    Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:6

    Topics: Administration, Oral; Alanine Transaminase; Animal Structures; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Aspartate Aminotransferases; Body Weight; Cell Line, Tumor; Creatinine; Docetaxel; Drug Stability; Ginsenosides; Humans; Ki-67 Antigen; Male; Mice; Mice, Nude; Prostatic Neoplasms; Solubility; Solvents; Taxoids; Tissue Distribution; Treatment Outcome; Xenograft Model Antitumor Assays

2009
Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
    The Prostate, 2010, Sep-15, Volume: 70, Issue:13

    Topics: Analysis of Variance; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Docetaxel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drugs, Chinese Herbal; Ginsenosides; Humans; Male; Mice; Mice, Nude; Prostatic Neoplasms; Taxoids

2010